The Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool is a two-part screening and brief assessment instrument for adults. It identifies problem use and possible substance use disorders across tobacco, alcohol, illicit drugs, and prescription medications, giving primary care and other clinicians a single validated way to ask about all four substance categories in one workflow.
Why healthcare providers use the TAPS
- Single screen for four categories. One instrument covers tobacco, alcohol, illicit drugs, and prescription medication misuse, so you ask about all of them in one place.
- Validated in primary care. It was developed and validated by the NIDA Clinical Trials Network for adult primary care patients.
- Brief and self-administered. Patients can complete the four screening questions on their own, which keeps it practical for busy visits.
- Two-stage design. A short frequency screen branches into deeper questions only for substances a patient reports, which saves time.
- Public domain. The tool is freely available at no cost, which lowers the barrier to routine screening.
Which settings use the TAPS?
- Primary care. The tool was designed for and validated in adult primary care patients.
- Integrated behavioral health. Teams embedding substance screening into medical visits use it to standardize how the question is asked.
- Community health centers. It supports routine screening where a single brief instrument fits limited visit time.
- Urgent and preventive care. Clinicians use it when a quick, structured substance history informs the encounter.
What does the TAPS measure?
The TAPS Tool measures the frequency and severity of substance use across four categories over the past year and, for positive screens, the past three months. It is a public domain instrument, so its domains can be described directly. Scoring is reported per substance rather than as one combined total.
- Tobacco and nicotine. Frequency of use and, on positive screens, signs of problem use or dependence.
- Alcohol. Frequency of any use and heavier or risky drinking patterns.
- Illicit drugs. Use of substances such as marijuana, cocaine, methamphetamine, and heroin.
- Prescription medication misuse. Non-prescribed or heavier-than-directed use of opioids, sedatives, and stimulants.
Scoring the TAPS
- Number of items. TAPS-1 has four screening questions, one per substance category, and TAPS-2 adds branching yes or no questions for each substance a patient screens positive on.
- Per-item scale. TAPS-1 uses a five-level frequency scale from never to daily or almost daily, and TAPS-2 uses yes or no items.
- Total score range. Scoring is per substance, and each substance receives a risk level from 0 to 2 or more, so there is no single overall total.
- Score direction. Higher scores indicate more frequent use and a greater likelihood of problem use or a substance use disorder.
The TAPS is a screening tool, not a diagnostic test. A positive result flags substances that warrant a closer look and guides clinical decision-making, but it does not by itself confirm a substance use disorder. Reported cut points perform better for some substances than others, so results should be interpreted alongside clinical judgment and, where indicated, further assessment.
| Score | Interpretation | Suggested next step |
|---|---|---|
| 0 | No reported use of that substance in the past three months | No further action indicated |
| 1 | Problem use for that substance | Consider further assessment |
| 2 or more | Higher risk, consistent with a possible substance use disorder | Consider further assessment or evaluation |
Best practices for administration
- Screen routinely. Offer the TAPS-1 to adult patients as part of standard intake rather than only when substance use is suspected.
- Let patients self-complete. Self-administration can improve disclosure compared with face-to-face questioning.
- Follow the branching logic. Administer TAPS-2 questions only for substances a patient screens positive on.
- Interpret per substance. Read each substance subscale on its own rather than adding scores into one total.
- Pair with a conversation. Use results to open a nonjudgmental discussion and decide on next steps together.
- Re-screen over time. Re-administer at appropriate intervals to track change when substance use is being followed.
How Zentake helps with the TAPS
- Automatic scoring. Zentake tallies each substance subscale on submit, so there is no hand-tallying.
- Longitudinal tracking. Re-send the TAPS on a schedule and view change over time.
- Risk flagging. Concerning responses are surfaced to your staff for review.
- Before the visit. Primary care practices have patients complete it from home on any device, so the clinician starts informed.
- HIPAA compliant. Data is encrypted, with a signed BAA on every plan.
References
McNeely J, Wu LT, Subramaniam G, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Annals of Internal Medicine. 2016. This study reported the tool's screening performance across substance categories.
Gryczynski J, McNeely J, Wu LT, et al. Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. Journal of General Internal Medicine. 2017. This validation supports the frequency-based cut points used to flag problem use and possible substance use disorder.
The TAPS Tool is maintained by the National Institute on Drug Abuse (NIDA) and is available in the public domain.
Last updated: August 2026